Fifth Third Bancorp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27M | Buy |
34,910
+19,485
| +126% | +$14.9M | 0.05% | 249 |
|
|
2025
Q4 | $11.9M | Buy |
15,425
+3,362
| +28% | +$2.28M | 0.04% | 239 |
|
|
2025
Q3 | $6.78M | Buy |
12,063
+1,929
| +19% | +$1.09M | 0.02% | 283 |
|
|
2025
Q2 | $5.32M | Buy |
10,134
+2,443
| +32% | +$1.36M | 0.02% | 304 |
|
|
2025
Q1 | $4.88M | Sell |
7,691
-952
| -11% | -$655K | 0.02% | 309 |
|
|
2024
Q4 | $6.16M | Sell |
8,643
-1,753
| -17% | -$1.47M | 0.02% | 286 |
|
|
2024
Q3 | $10.9M | Buy |
10,396
+2,143
| +26% | +$2.38M | 0.04% | 233 |
|
|
2024
Q2 | $8.67M | Sell |
8,253
-119
| -1% | -$115K | 0.03% | 248 |
|
|
2024
Q1 | $8.06M | Sell |
8,372
-240
| -3% | -$228K | 0.03% | 259 |
|
|
2023
Q4 | $7.56M | Sell |
8,612
-62
| -0.7% | -$51.1K | 0.03% | 263 |
|
|
2023
Q3 | $7.14M | Buy |
8,674
+13
| +0.2% | +$10.2K | 0.03% | 267 |
|
|
2023
Q2 | $6.22M | Buy |
8,661
+178
| +2% | +$137K | 0.03% | 291 |
|
|
2023
Q1 | $6.97M | Sell |
8,483
-297
| -3% | -$224K | 0.03% | 275 |
|
|
2022
Q4 | $6.33M | Buy |
8,780
+47
| +0.5% | +$34.7K | 0.03% | 291 |
|
|
2022
Q3 | $6.02M | Buy |
8,733
+192
| +2% | +$121K | 0.03% | 291 |
|
|
2022
Q2 | $5.05M | Sell |
8,541
-4,279
| -33% | -$2.78M | 0.02% | 323 |
|
|
2022
Q1 | $8.95M | Sell |
12,820
-337
| -3% | -$213K | 0.04% | 277 |
|
|
2021
Q4 | $8.31M | Buy |
13,157
+697
| +6% | +$429K | 0.03% | 291 |
|
|
2021
Q3 | $7.54M | Buy |
12,460
+3,983
| +47% | +$2.47M | 0.03% | 297 |
|
|
2021
Q2 | $4.74M | Sell |
8,477
-11,425
| -57% | -$5.79M | 0.02% | 349 |
|
|
2021
Q1 | $9.42M | Sell |
19,902
-3,460
| -15% | -$1.68M | 0.04% | 262 |
|
|
2020
Q4 | $11.3M | Sell |
23,362
-2,965
| -11% | -$1.6M | 0.06% | 227 |
|
|
2020
Q3 | $14.7M | Buy |
26,327
+713
| +3% | +$432K | 0.08% | 183 |
|
|
2020
Q2 | $16M | Buy |
25,614
+7,712
| +43% | +$4.38M | 0.1% | 171 |
|
|
2020
Q1 | $8.74M | Sell |
17,902
-18,317
| -51% | -$7.56M | 0.06% | 213 |
|
|
2019
Q4 | $13.6M | Buy |
36,219
+612
| +2% | +$206K | 0.08% | 202 |
|
|
2019
Q3 | $9.88M | Buy |
35,607
+23,304
| +189% | +$6.9M | 0.06% | 231 |
|
|
2019
Q2 | $3.85M | Buy |
12,303
+11,811
| +2,401% | +$3.93M | 0.02% | 322 |
|
|
2019
Q1 | $202K | Buy |
492
+74
| +18% | +$30.5K | ﹤0.01% | 884 |
|
|
2018
Q4 | $156K | Sell |
418
-498
| -54% | -$182K | ﹤0.01% | 917 |
|
|
2018
Q3 | $370K | Buy |
916
+98
| +12% | +$37.3K | ﹤0.01% | 745 |
|
|
2018
Q2 | $282K | Sell |
818
-57
| -7% | -$17.8K | ﹤0.01% | 809 |
|
|
2018
Q1 | $301K | Buy |
875
+437
| +100% | +$152K | ﹤0.01% | 778 |
|
|
2017
Q4 | $165K | Buy |
438
+69
| +19% | +$27.9K | ﹤0.01% | 922 |
|
|
2017
Q3 | $165K | Sell |
369
-12
| -3% | -$5.71K | ﹤0.01% | 934 |
|
|
2017
Q2 | $187K | Buy |
381
+35
| +10% | +$15.3K | ﹤0.01% | 912 |
|
|
2017
Q1 | $134K | Sell |
346
-11
| -3% | -$4.08K | ﹤0.01% | 1002 |
|
|
2016
Q4 | $131K | Sell |
357
-100
| -22% | -$38K | ﹤0.01% | 1020 |
|
|
2016
Q3 | $184K | Sell |
457
-79
| -15% | -$31.7K | ﹤0.01% | 945 |
|
|
2016
Q2 | $187K | Sell |
536
-123
| -19% | -$47.4K | ﹤0.01% | 932 |
|
|
2016
Q1 | $238K | Sell |
659
-88
| -12% | -$36.3K | ﹤0.01% | 874 |
|
|
2015
Q4 | $406K | Sell |
747
-36
| -5% | -$19.5K | ﹤0.01% | 783 |
|
|
2015
Q3 | $364K | Buy |
783
+53
| +7% | +$28.5K | ﹤0.01% | 815 |
|
|
2015
Q2 | $372K | Buy |
730
+90
| +14% | +$43.9K | ﹤0.01% | 825 |
|
|
2015
Q1 | $289K | Buy |
640
+42
| +7% | +$17.8K | ﹤0.01% | 898 |
|
|
2014
Q4 | $245K | Buy |
598
+8
| +1% | +$3.15K | ﹤0.01% | 909 |
|
|
2014
Q3 | $213K | Sell |
590
-19
| -3% | -$6.37K | ﹤0.01% | 940 |
|
|
2014
Q2 | $172K | Buy |
609
+23
| +4% | +$6.82K | ﹤0.01% | 1004 |
|
|
2014
Q1 | $176K | Sell |
586
-1,055
| -64% | -$325K | ﹤0.01% | 963 |
|
|
2013
Q4 | $452K | Buy |
1,641
+555
| +51% | +$160K | ﹤0.01% | 746 |
|
|
2013
Q3 | $340K | Sell |
1,086
-1,308
| -55% | -$344K | ﹤0.01% | 786 |
|
|
2013
Q2 | $538K | Buy |
+2,394
| New | +$557K | 0.01% | 710 |
|
Other funds holding REGN
VCM
N
Fifth Third Bancorp's REGN Position: Q1 2026 in Review
Fifth Third Bancorp increased its Regeneron Pharmaceuticals (REGN) stake by 126% in Q1 2026, buying an estimated $14.9M and bringing the position to 34,910 shares worth $27M. The position accounts for 0.05% of the portfolio, ranked #249.
Fifth Third Bancorp first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Fifth Third Bancorp held 34,910 shares of Regeneron Pharmaceuticals worth $27M as of Q1 2026.
- Fifth Third Bancorp bought 19,485 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $14.9M.
- Regeneron Pharmaceuticals made up 0.05% of Fifth Third Bancorp's portfolio in Q1 2026, its #249 holding.
- Fifth Third Bancorp first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.